Found: 15
Select item for more details and to access through your institution.
The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300.
- Published in:
- Cellular Microbiology, 2011, v. 13, n. 10, p. 1542, doi. 10.1111/j.1462-5822.2011.01640.x
- By:
- Publication type:
- Article
Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7227, doi. 10.3390/ijms23137227
- By:
- Publication type:
- Article
The worm turns for antimicrobial discovery.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 9, p. 1098, doi. 10.1038/nbt0906-1098
- By:
- Publication type:
- Article
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.
- Published in:
- Nature Genetics, 2015, v. 47, n. 9, p. 1079, doi. 10.1038/ng.3374
- By:
- Publication type:
- Article
Cell wall assembly in Bacillus subtilis: how spirals and spaces challenge paradigms.
- Published in:
- Molecular Microbiology, 2006, v. 60, n. 5, p. 1077, doi. 10.1111/j.1365-2958.2006.05169.x
- By:
- Publication type:
- Article
Toll‐like receptor 4 is activated by platinum and contributes to cisplatin‐induced ototoxicity.
- Published in:
- EMBO Reports, 2021, v. 22, n. 5, p. 1, doi. 10.15252/embr.202051280
- By:
- Publication type:
- Article
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity.
- Published in:
- NPJ Genomic Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41525-021-00199-4
- By:
- Publication type:
- Article
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 5, p. 1143, doi. 10.1111/bcp.13218
- By:
- Publication type:
- Article
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 3, p. 683, doi. 10.1111/bcp.13008
- By:
- Publication type:
- Article
Manipulation of host-cell pathways by bacterial pathogens.
- Published in:
- Nature, 2007, v. 449, n. 7164, p. 827, doi. 10.1038/nature06247
- By:
- Publication type:
- Article
Pharmacogenomics of Cisplatin‐Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of Research.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 2, p. 350, doi. 10.1002/cpt.1483
- By:
- Publication type:
- Article
The <i>Salmonella</i> Type III Effector SspH2 Specifically Exploits the NLR Co-chaperone Activity of SGT1 to Subvert Immunity.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 7, p. 1, doi. 10.1371/journal.ppat.1003518
- By:
- Publication type:
- Article
An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0276541
- By:
- Publication type:
- Article
Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0175711
- By:
- Publication type:
- Article